Cargando…
Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia: Can an early dose herald a better outcome?
Autores principales: | Lo, Ching-Lung, Syue, Ling-Shan, Ko, Wen-Chien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496938/ https://www.ncbi.nlm.nih.gov/pubmed/34654666 http://dx.doi.org/10.1016/j.jmii.2021.07.016 |
Ejemplares similares
-
OLIGO-LESIONAL ERUPTIONS RAPIDLY FOLLOWING A HERALD PLAQUE: ABORTIVE PITYRIASIS ROSEA
por: Zawar, Vijay
Publicado: (2011) -
Has China faced only a herald wave of SARS-CoV-2?
por: Flahault, Antoine
Publicado: (2020) -
Asymptomatic Subcutaneous Nodules Heralding Recurrence of Gastric Adenocarcinoma
por: Dhawan, Amit Kumar, et al.
Publicado: (2016) -
Bortezomib, Lenalidomide and Dexamethasone as Induction Therapy Prior to Autologous Transplantation in Multiple Myeloma: The More Is Likely the Better
por: Mohty, Mohamad, et al.
Publicado: (2020) -
Peyronie's Disease Treated with Oral Weekly Dexamethasone and Continuous Low-dose Cyclophosphamide
por: Gupta, Ramji, et al.
Publicado: (2014)